Therapeutic Applications: Depression, Anxiety, PTSD, and Substance Use
Where Psychedelic Therapy Is Being Studied
Depression and Anxiety
A major research focus is depression, including treatment-resistant depression, as well as anxiety associated with serious illness. Psychedelic sessions may produce intense emotional and cognitive experiences that support change.
PTSD and Substance Use
MDMA-assisted therapy has been studied most closely for PTSD, while psilocybin and other compounds have been explored for tobacco, alcohol, and other substance use disorders.
Condition and Research Focus
| Condition | Common research interest |
|---|---|
| Major depression | Mood improvement and cognitive flexibility |
| Serious-illness anxiety | Reduced fear and existential distress |
| PTSD | Processing trauma with structured support |
| Substance use disorders | Changing behavior and motivation |
Which condition has been especially associated with MDMA-assisted psychotherapy research?
MDMA has been most prominently studied in trauma-related psychotherapy.
Correct answer: PTSD
What is a common research target for psilocybin besides depression?
Psilocybin has been studied for anxiety, especially in serious illness contexts.
Correct answer: anxiety
Important Reminder
Clinical promise does not mean self-treatment is safe or effective.
Symptom Targets
Internal distress
- Depression
- Anxiety
- Existential fear
Trauma-related symptoms
- Hyperarousal
- Avoidance
- Intrusive memories